Johnson & Johnson Recalls 360,000 Surgical Wound Drains

According to an article written by Jonathan D. Rockoff in the Wall Street Journal Health Blog on April 5, 2011, Johnson & Johnson recently announced a recall of approximately 360,000 products sold in the United States for use draining surgical wounds. This recall was also reported in the Dow Jones Newswires.

Johnson &Johnson’s Ethicon division, which makes the Blake Silicon Drains, J-VAC reservoirs and other withdrawn products, states that it has not received any reports of side effects. However, Johnson & Johnson said it decided to recall the devices after customers complained that the sterile packaging could be compromised. Johnson & Johnson claims the problem on an unidentified contract manufacturer.

According to the Wall Street Journal’s article, the following is a list of Johnson & Johnson’s recent recalls:

  • Johnson & Johnson Animas unit recalled over 384,000 insulin-pump cartridges in the U.S. and France, claiming they have the potential to leak and provide an insufficient dose, as Dow Jones Newswires reported.
  • Dow Jones Newswires reported that Johnson & Johnson’s Ethicon unit issued an alert in the United Kingdom that it was recalling approximately 585,000 surgical sutures. The recalled sutures were primarily sold in Europe.
  • Johnson & Johnson recalled over 667,000 Sudafed packages at the wholesale level after a typographical error was found on the packaging which stated “do not divide, crush, chew, or dissolve the tablet”. Customers need not return the Sudafed, which have the correct wording on the blister packs. According to Johnson & Johnson, no adverse events have been reported as a result of the typographical error.
  • Johnson & Johnson pulled at least 395 injection pens preloaded with rheumatoid-arthritis drug Simponi because they may not deliver a sufficient dose of Simponi.
  • According to the Dow Jones Newswire Johnson & Johnson’s Ethicon division recently recalled 700,000 vials of a liquid wound sealant and a hernia-treatment product.
  • Johnson & Johnson recalled 70,000 syringes preloaded with its Invega injectable anti-psychotic drug because cracks were found in the syringes that could in theory cause infections or under-dosing in users.
  • Johnson & Johnson stated it would recall 43 million bottles of Benadryl, Sinutab, Tylenol and Sudafed because they were made at the company’s Ft. Washington, Pa., factory when the equipment may have been improperly cleaned. Furthermore, Johnson & Johnson stated it would recall nearly 4 million units of Rolaids because of labeling problems.
  • Johnson & Johnson stated it would recall all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews and Rolaids Multi-Symptom Plus Anti-Gas Softchews because of consumer compaints of foreign-particle contamination.
  • Johnson & Johnson recalled twelve different Mylanta liquid products and one AlternaGEL product because the labeling failed to mention the presence of small amounts of alcohol. Additionally, Johnson & Johnson widened its recall of daily-use contact lenses in Japan and elsewhere because of traces of an acid that can cause stinging. Contact lenses made in the U.S. are not affected.
  • Johnson & Johnson recalled three Tylenol Cold Multi-Symptom products, because of an alcohol labeling issue. Johnson & Johnson claims that consumers can continue taking the medications.
  • Johnson & Johnson recalled children’s Motrin and Benadryl products. Johnson & Johnson stated that the medications were not dangerous and consumers did not need to stop taking them.
  • Johnson & Johnson recalled 127,000 bottles of Tylenol 8-Hour caplets because of a musty odor.
  • Johnson & Johnson’s DePuy Orthopedics division recalled two hip implants from the market as a result of an unusually high rate of replacement surgeries.
  • Johnson & Johnson recalled approximately 100,000 boxes of 1-Day Acuvue TruEye contact lenses. This recall was recently expanded.
  • Johnson & Johnson recalled various over the counter medications, including varieties of Benadryl, Tylenol and Motrin. This was an expansion of a recall of musty-smelling products made at a plant in Puerto Rico.
  • Johnson & Johnson expanded its recall of drugs made at the Puerto Rican plant by five lots. The largest lot of children’s medicines were pulled in the spring.
  • Johnson & Johnson recalled Tylenol Arthritis Pain Caplets because of a musty odor.
  • Johnson & Johnson recalled batches of Motrin, but has been criticized for a previous so-called “phantom recall” of the product.

Boyd B. Newton is an expert Atlanta Product Liability Lawyer. For more information, visit